Artificial Intelligence (AI) has rapidly become a transformative force in various industries, including life sciences. In regulatory pharmacovigilance, AI offers unprecedented opportunities to enhance drug safety monitoring, data analysis, and decision-making processes. However, with these advancements come challenges in ensuring the regulatory acceptability of AI-driven systems. This eBook explores the current perspectives on the regulatory acceptability of AI in pharmacovigilance, highlighting the opportunities, challenges, and best practices for life sciences companies aiming to integrate AI into their regulatory frameworks.
Fill the form below to download the e-Book
